Qualitative and quantitative composition:
1 capsule for adults contains: Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis: 7 mg.
1 capsule for children contains: Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis: 3,5 mg.
Therapeutic indications:
Prevention of recurrent infections of the airways and acute infectious exacerbations of chronic bronchitis. Comedication in the treatment of acute airway infections.
Posology and method of administration:
Oral route.
Adults:
Preventive treatment and/or consolidation therapy: 1 capsule daily on an empty stomach during 10 consecutive days per month for 3 months. Treatment of acute episodes: 1 capsule daily on an empty stomach until disappearance of the symptoms (but for at least 10 days). In cases in which antibiotics are needed, the administration of Broncho-Vaxom should be associated preferably from the start of therapy.
Children:
The capsule can be opened and the content poured into a drink (water, fruit juice, milk, etc.). Preventive treatment and/or consolidation therapy: 1 capsule daily on an empty stomach during 10 consecutive days per month for 3 months. Treatment of acute episodes: 1 capsule daily on an empty stomach until disappearance of the symptoms (but for at least 10 days). In cases in which antibiotics are needed, the administration of Broncho-Vaxom should be associated preferably from the start of therapy.